U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653386) titled 'Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic Dermatitis' on June 04.

Brief Summary: Atopic dermatitis (AD) is a chronic skin disorder, which negatively impacts up to 20% children and 3% adults in the world. The main AD treatments aim to regress clinical manifestations, improve and restore skin lesions. Daily moisturizing has also been shown to have the ability to protect the skin, increase skin elasticity and reduce the severity of AD. In the past few decades, Korea has been a well-known country with cosmetic companies and products derived from nature. Carboexpert is also one of them. Since its inception, ...